HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

• Click on your picture/name in Zoom
• Click on rename
• enter <name> - <organization>

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

2022-06-06 Agenda/Meeting Notes -  accepted by general consent

Project Review

Project Proposals

• Project Proposals in Review 
  • added comments for

Project Scope Statements

• Project Scope Statements - none to review

External Meeting Review

Catalog Updates (John Hatem)

• 10 Jun 2022 - no updates

Workflow Update (John Hatem) 

• 10 Jun 2022- no updates

Healthcare Product Update (John Hatem)

• 13 Jun 2022 - no updates 

EHR conformant reconciled medication list (cRML)

• 13 Jun 2022 - no updates

NCPDP Updates (NCPDP Members)

WG18 Patient Consent TG:

• 13 Jun 2022 
  • Addition of Consent to HL7 Specialty Rx FHIR IG  will be balloted as a new version of the Specialty Medication Enrollment Guide in September
  • Connectathon
    • New application was created that illustrates the content of the implementation guide and it demonstrates how the application will use the standard that is defined to request the consent and provide the appropriate consent form to the clinic.
    • The clinic can see the request and work it in to the workflow process, update the request, complete the request, and view it.
    • Focus is on the exchange process while the patient is at the clinic
    • In this process there is still exchange of PDFs
  • Link for Consent Simulator - Patient Requester View
    • From this page it is possible to view the form, submit request and view the status of consent
  • There will be a discussion with the HL7 Community Based Care and Privacy WG in the next couple of weeks to review the plan and what was learned at the Connectathon
    • They will be co-sponsoring the effort to add consent to the guide and take this to ballot
  • NCPDP Meetings are scheduled for June 23, July 7, and July 21st at 11:00 am US Central Time
  • NIB - Melva to create draft and send to Frank to complete

MC Consumer and Provider RTPB Standards Monitoring Sub-Task Group

• 13 Jun 2022 
  • HL7® FHIR® Jira tickets status for RTPB Standard vs Consumer RTPB Check Imp Guide gaps have been submitted. Waiting on CARIN Alliance. The sub-TG continues to monitor state legislation and regulations.
  • NCPDP Meetings are scheduled for June 27, July 11 and July 25 at 12:00 pm US Central Time

WG14 Consultant Pharmacist TG

• see in projects below

WG18 Specialty Requirements for ePrescribing Task Group

• 13 Jun 2022 
  • This is rolled into the Patient Consent Task Group at this point in time.

All NCPDP Meeting information can be obtained at https://dms.ncpdp.org/

Projects

PDex Formulary (Corey)

• 13 Jun 2022 - working with Courtenay to resolve issue with RxNorm Codes - multiple NDCs for a single RxNorm
  • Ballot reconciliation sheet uploaded
  • Requested withdrawals

Pharmacist Consult Note (Scott)

• 06 Jun 2022 
  • NCPDP TG decided to continue with the HL7/NCPDP guidance document and possibly tackle an IG at a later date.
  • NCPDP meetings are scheduled for June 16, June 30, and July 14 at 10:00 am US Central Time
• 13 Jun 2022 
  • NIB for approval - reviewed and updated
  • Motion - Scott and Margaret to approve NIB - 11-0-0 Carried

FHIR (Group)

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

See updates 

FHIR-37475 - Getting issue details... STATUS

FHIR-37452 - Getting issue details... STATUS

Any Other Business

• Co-chair nominations must be in by June 15
  • Danielle will not be running 
  • Next year we will have 4 positions open

Next meeting:

• 20 Jun 2022